116387-59-8

Basic information

• Product Name: (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium
• CAS NO: 116387-59-8
• Molecular Formula: C₁₈H₉BrN₂O₂
• Molecular Weight: 370.2194
• Mol File: 116387-59-8.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium(116387-59-8)
• EPA Substance Registry System: (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium(116387-59-8)

Safety Data

• Hazardous Substances Data: 116387-59-8(Hazardous Substances Data)

Usage

Description

(2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium is a complex organic molecule with a naphthoquinolinium core structure. It contains a bromine atom, a cyano group, and a methyl group, as well as carbonyl functional groups. This unique structure endows it with potential biological activities and makes it a promising candidate for medicinal chemistry and pharmaceutical research.

Uses

Used in Medicinal Chemistry:
(2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium is used as a compound of interest in medicinal chemistry for its unique structure and potential biological activities. Its naphthoquinolinium core, along with the bromine, cyano, and methyl groups, may contribute to its interactions with biological targets and its overall pharmacological profile.
Used in Pharmaceutical Research:
In pharmaceutical research, (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium is utilized as a starting point for the development of new drugs. Its complex structure and functional groups may be optimized to target specific diseases or conditions, potentially leading to the discovery of novel therapeutic agents.
Further investigation and research are needed to fully understand the properties and potential uses of (2R,3aR,10R,11cR)-10-bromo-3a-cyano-2-methyl-3,9-dioxo-2,3a,4,9,10,11c-hexahydro-3H-naphtho[1,2,3-de]quinolinium, as its current applications are based on its unique structure and potential biological activities.

Upstream product

• 39774-39-5 chloro-acetic acid-[(4-bromo-9,10-dioxo-9,10-dihydro-[1]anthryl)-methyl-amide] 
• 128-93-8 1-bromo-4-(methylamino)-9,10-anthracenedione